U.S. Diabetes Devices Market Size, Share & Trends Analysis Report By Type (Blood Glucose Monitoring Devices, Insulin Delivery Devices), By Distribution Channel, By End-use (Hospitals, Homecare), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Type
                        1.2.2. Distribution Channel
                        1.2.3. End Use
                        1.2.4. Regional scope
                        1.2.5. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in MEA
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Type outlook
                        2.2.2. Distribution Channel outlook
                        2.2.3. End Use outlook
                        2.2.4. Regional outlook
                    2.3. Competitive Insights
Chapter 3. U.S. Diabetes Devices Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. Growing prevalence of obesity and diabetes
                            3.2.1.2. Technological Innovations & Product Advancements
                            3.2.1.3. Growing focus on diabetes care
                            3.2.1.4. Untapped opportunities in developing economies
                        3.2.2. Market restraint analysis
                            3.2.2.1. Stringent regulatory policies and regulations
                            3.2.2.2. High cost of devices
                    3.3. Diabetes Devices Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Economic landscape
                            3.3.2.3. Social landscape
                            3.3.2.4. Technological landscape
                            3.3.2.5. Environmental landscape
                            3.3.2.6. Legal landscape
Chapter 4. U.S. Diabetes Devices Market: Type Estimates & Trend Analysis
                    4.1. Type Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Diabetes Devices Market by Type Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    4.5. Blood Glucose Monitoring Devices
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.5.2. Self-Monitoring Devices
                            4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.5.2.2. Blood Glucose Meters
                                4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.5.2.3. Testing Strips
                                4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.5.2.4. Lancets
                                4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.5.3. Continuous Glucose-Monitoring Devices
                            4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.5.3.2. Sensors
                                4.5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.5.3.3. Transmitters
                                4.5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.5.3.4. Receiver
                                4.5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Insulin Delivery Devices
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.6.2. Insulin Pumps
                            4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.6.3. Insulin Pens
                            4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.6.4. Insulin Syringes
                            4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.6.5. Insulin Jet injectors
                            4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. Diabetes Devices Market: Distribution Channel Estimates & Trend Analysis
                    5.1. Distribution Channel Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. Global Diabetes Devices Market by Distribution Channel Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    5.5. Hospital Pharmacies
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Retail Pharmacies
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Diabetes Clinics/Centers
                        5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.8. Online Pharmacies
                        5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.9. Others
                        5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. Diabetes Devices Market: End Use Estimates & Trend Analysis
                    6.1. End Use Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. Global Diabetes Devices Market by End Use Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                    6.5. Hospitals
                        6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Diagnostic Centers
                        6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    6.7. Homecare
                        6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Key Company Market Share Analysis, 2023
                    7.4. Company Position Analysis, 2023
                    7.5. Company Categorization (Emerging Players, Innovators, and Leaders)
                    7.6. Company Profiles
                        7.6.1. Medtronic plc
                            7.6.1.1. Company overview
                            7.6.1.2. Financial performance
                            7.6.1.3. Product benchmarking
                            7.6.1.4. Strategic initiatives
                        7.6.2. Abbott Laboratories
                            7.6.2.1. Company overview
                            7.6.2.2. Financial performance
                            7.6.2.3. Product benchmarking
                            7.6.2.4. Strategic initiatives
                        7.6.3. Ascensia Diabetes Care Holdings AG F.Hoffmann-La-Ltd.
                            7.6.3.1. Company overview
                            7.6.3.2. Financial performance
                            7.6.3.3. Product benchmarking
                            7.6.3.4. Strategic initiatives
                        7.6.4. Dexcom, Inc. Bayer AG
                            7.6.4.1. Company overview
                            7.6.4.2. Financial performance
                            7.6.4.3. Product benchmarking
                            7.6.4.4. Strategic initiatives
                        7.6.5. Hoffmann-La Roche Ltd. Lifesc
                            7.6.5.1. Company overview
                            7.6.5.2. Financial performance
                            7.6.5.3. Product benchmarking
                            7.6.5.4. Strategic initiatives
                        7.6.6. B Braun Melsungen AG
                            7.6.6.1. Company overview
                            7.6.6.2. Financial performance
                            7.6.6.3. Product benchmarking
                            7.6.6.4. Strategic initiatives
                        7.6.7. Lifescan, Inc.
                            7.6.7.1. Company overview
                            7.6.7.2. Financial performance
                            7.6.7.3. Product benchmarking
                            7.6.7.4. Strategic initiatives
                        7.6.8. Dexcom Inc.
                            7.6.8.1. Company overview
                            7.6.8.2. Financial performance
                            7.6.8.3. Product benchmarking
                            7.6.8.4. Strategic initiatives
                        7.6.9. Insulet Corporation
                            7.6.9.1. Company overview
                            7.6.9.2. Financial performance
                            7.6.9.3. Product benchmarking
                            7.6.9.4. Strategic initiatives
                        7.6.10. Ypsomed Holdings
                            7.6.10.1. Company overview
                            7.6.10.2. Financial performance
                            7.6.10.3. Product benchmarking
                            7.6.10.4. Strategic initiatives
                        7.6.11. Companion Medical
                            7.6.11.1. Company overview
                            7.6.11.2. Financial performance
                            7.6.11.3. Product benchmarking
                            7.6.11.4. Strategic initiatives
                        7.6.12. Sanofi
                            7.6.12.1. Company overview
                            7.6.12.2. Financial performance
                            7.6.12.3. Product benchmarking
                            7.6.12.4. Strategic initiatives
                        7.6.13. Valeritas Holding Inc.
                            7.6.13.1. Company overview
                            7.6.13.2. Financial performance
                            7.6.13.3. Product benchmarking
                            7.6.13.4. Strategic initiatives
                        7.6.14. Novo Nordisk
                            7.6.14.1. Company overview
                            7.6.14.2. Financial performance
                            7.6.14.3. Product benchmarking
                            7.6.14.4. Strategic initiatives
                        7.6.15. Arkray, Inc.
                            7.6.15.1. Company overview
                            7.6.15.2. Financial performance
                            7.6.15.3. Product benchmarking
                            7.6.15.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 North America diabetes devices market, By country, 2018 - 2030 (USD Million)
Table 4 North America diabetes devices market, By type, 2018 - 2030 (USD Million)
Table 5 North America diabetes devices market, By distribution channel, 2018 - 2030 (USD Million)
Table 6 North America diabetes devices market, By end use, 2018 - 2030 (USD Million)
Table 7 U.S. diabetes devices market, By type, 2018 - 2030 (USD Million)
Table 8 U.S. diabetes devices market, By distribution channel, 2018 - 2030 (USD Million)
Table 9 U.S. diabetes devices market, By end use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Diabetes devices market: Market outlook
Fig. 14 Diabetes devices market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Diabetes devices market driver impact
Fig. 20 Diabetes devices market restraint impact
Fig. 21 Diabetes devices market: type movement analysis
Fig. 22 Diabetes devices market: type outlook and key takeaways
Fig. 23 Blood glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 24 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 25 Blood glucose meters market estimates and forecast, 2018 - 2030
Fig. 26 Testing strips market estimates and forecast, 2018 - 2030
Fig. 27 Lancets market estimates and forecast, 2018 - 2030
Fig. 28 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 29 Sensors market estimates and forecast, 2018 - 2030
Fig. 30 Transmitters market estimates and forecast, 2018 - 2030
Fig. 31 Receivers market estimates and forecast, 2018 - 2030
Fig. 32 Insulin delivery devices market estimates and forecast, 2018 - 2030
Fig. 33 Insulin pumps market estimates and forecast, 2018 - 2030
Fig. 34 Insulin pens market estimates and forecast, 2018 - 2030
Fig. 35 Insulin syringes market estimates and forecast, 2018 - 2030
Fig. 36 Insulin jet injectors market estimates and forecast, 2018 - 2030
Fig. 37 Diabetes devices market: distribution channel movement analysis
Fig. 38 Diabetes devices market: distribution channel outlook and key takeaways
Fig. 39 Hospital pharmacies market estimates and forecast, 2018 - 2030
Fig. 40 Retail pharmacies market estimates and forecast, 2018 - 2030
Fig. 41 Diabetes clinics/centers market estimates and forecast, 2018 - 2030
Fig. 42 Online pharmacies market estimates and forecast, 2018 - 2030
Fig. 43 Others market estimates and forecast, 2018 - 2030
Fig. 44 Diabetes devices market: end use movement analysis
Fig. 45 Diabetes devices market: end use outlook and key takeaways
Fig. 46 Hospitals market estimates and forecast, 2018 - 2030
Fig. 47 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 48 Homecare market estimates and forecast, 2018 - 2030
Fig. 49 U.S. market estimates and forecast, 2018 - 2030